Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone

Lyme disease is a vector-borne illness of North America and Europe transmitted by Borrelia burgdorferi, over 30,000 cases are reported in the United States yearly. Patients typically present having early localized disease with fevers, headaches, myalgias, and a single erythema migrans. Usually, oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Naeem, Muhammad, Enos, Derek, Shah, Shazia, Patel, Nidhi, Fisher, Tara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359626/
https://www.ncbi.nlm.nih.gov/pubmed/34395132
http://dx.doi.org/10.7759/cureus.16354
Descripción
Sumario:Lyme disease is a vector-borne illness of North America and Europe transmitted by Borrelia burgdorferi, over 30,000 cases are reported in the United States yearly. Patients typically present having early localized disease with fevers, headaches, myalgias, and a single erythema migrans. Usually, oral doxycycline is administered with a good disease prognosis but we report the case of a 58-year-old male who presented with Lyme disease diagnosed by immunoassay; he was treated with doxycycline but was refractory and saw an improvement in his symptoms with IV ceftriaxone.

Ejemplares similares